Developed the first genomic test for personalized HER2+ breast cancer treatments
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.
Ten IDIBAPS groups are looking for candidates to apply for one of the 35 pre-doctoral scholarships offered by the INPhINIT Incoming program of the La1
The COVID-19 pandemic and lockdown have increased anxiety and depression in many people, but a study has found that eating a balanced diet can help p1
Researchers at Hospital Clínic-IDIBAPS are leading the CIBERESUCICOVID project, which seeks to identify the risk and prognosis factors of patients wi1
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
Dr. Josep Baselga, an internationally renowned medical oncologist, died of this degenerative disease on 21 March 2021. The meeting was attended1
The study shows how the average life of the virus is drastically reduced, in transplanted patients and cell cultures alike.
The inhibition of this molecule, in addition to reducing the predisposition towards developing the disease, also reduces the alteration of the microb1
A study conducted at Hospital Clínic analysed the genetic profile of more than 300 patients with solid tumours using a liquid biopsy blood test, resu1
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1